Model-based rational design of an oncolytic virus with improved therapeutic potential-Reference-Cited by-同舟云学术

Model-based rational design of an oncolytic virus with improved therapeutic potential

Published:2013-06-14 Issue:1 Volume:4 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Le Bœuf Fabrice,Batenchuk Cory,Vähä-Koskela Markus,Breton Sophie,Roy Dominic,Lemay Chantal,Cox Julie,Abdelbary Hesham,Falls Theresa,Waghray Girija,Atkins Harold,Stojdl David,Diallo Jean-Simon,Kærn Mads,Bell John C.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms2974.pdf

Reference44 articles.

1. Naik, S. Nace, R. Barber, G. N. & Russell, S. J. Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-beta. Cancer Gene Ther. 19, 443–450 (2012).

2. Russell, S. J. & Peng, K. W. Viruses as anticancer drugs. Trends Pharmacol. Sci. 28, 326–333 (2007).

3. Stojdl, D. F. et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 6, 821–825 (2000).

4. Parato, K. A. Senger, D. Forsyth, P. A. & Bell, J. C. Recent progress in the battle between oncolytic viruses and tumours. Nat. Rev. Cancer 5, 965–976 (2005).

5. Colina, R. et al. Translational control of the innate immune response through IRF-7. Nature 452, 323–328 (2008).

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy;Nature Communications;2024-08-23

2. Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies;Life Sciences;2024-07

3. Emerging Nano-/Biotechnology Drives Oncolytic Virus-Activated and Combined Cancer Immunotherapy;Research;2023-01

4. Improving immunovirotherapies: the intersection of mathematical modelling and experiments;ImmunoInformatics;2022-06

5. The intratumoral microbiome: Characterization methods and functional impact;Cancer Letters;2021-12